Long-term survival rates of thalassemia patients following hematopoietic stem cell transplantation: A systematic review and meta-analysis
Marcella Adisuhanto, Alver Prasetya, Alius Cahyadi, Amaylia Oehadian · 2026
Read Long-term survival rates of thalassemia patients following hematopoietic stem cell transplantation: A systematic review and meta-analysis by Marcella Adisuhanto, Alver Prasetya, Alius Cahyadi, Amaylia Oehadian (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13448898.txt.
Description
Marcella Adisuhanto and colleagues synthesize in 2026 what is known about how long patients with thalassemia live after a stem cell transplant, the only treatment that can cure the blood disorder. Their search of medical databases through July 2024 found four studies covering 616 transplanted patients. Survival estimates were pooled with a random-effects model, and study quality was checked with a standard prognosis tool.
Pooled long-term survival came to 85 percent. Survival stood at 86.8 percent at fifteen years, 89.2 percent at twenty years, 82.6 percent at thirty years, and 81.4 percent at thirty-nine years after transplant. Leaving any single study out did not move the pooled figure significantly. The authors urge cautious reading, given the small patient total and differing use of immune-suppressing antithymocyte globulin across studies, yet the picture supports transplantation as a durable cure for many patients.
Catalog record
| CREATOR | Marcella Adisuhanto, Alver Prasetya, Alius Cahyadi, Amaylia Oehadian |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |